Efficacy and safety of integrated Chinese and Western medicine in advanced pancreatic cancer: A double-center retrospective cohort study

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 2

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastrointest Oncol. Feb 15, 2026; 18(2): 114690
Published online Feb 15, 2026. doi: 10.4251/wjgo.v18.i2.114690

Table 3 Comparison of tumor markers before and after treatment in the two groups, median (interquartile ranges)

Group	Time	CA199 (U/mL)	CA125 (U/mL)	CEA (ng/mL)
Integration of Chinese and Western medicine group (n = 66)	Before treatment	853.31 (20.70, 8560.03)	55.90 (24.90, 252.70)	5.67 (2.59, 18.83)
Integration of Chinese and Western medicine group (n = 66)	After treatment	317.95 (28.35, 5593.16)^a	47.50 (16.80, 169.10)^a	6.94 (3.40, 21.81)
Western medicine group (n = 70)	Before treatment	455.29 (55.77, 2722.84)	66.12 (23.67, 150.46)	6.16 (3.30, 24.10)
Western medicine group (n = 70)	After treatment	628.21 (42.18, 1902.00)^a	67.65 (20.43, 200.30)	8.81 (4.08, 28.38)

^aP < 0.05 indicates a significant difference in intragroup comparison.

CA: Carbohydrate antigen; CEA: Carcinoembryonic antigen.

Citation: Wang YR, Wang JQ, Chen XJ, Yan Y, Zhang Y, Li MY, Wang W, Fan TY, Jiao PF, Zhou CF. Efficacy and safety of integrated Chinese and Western medicine in advanced pancreatic cancer: A double-center retrospective cohort study. World J Gastrointest Oncol 2026; 18(2): 114690
URL: https://www.wjgnet.com/1948-5204/full/v18/i2/114690.htm
DOI: https://dx.doi.org/10.4251/wjgo.v18.i2.114690

Wang YR, Wang JQ, Chen XJ, Yan Y, Zhang Y, Li MY, Wang W, Fan TY, Jiao PF, Zhou CF. Efficacy and safety of integrated Chinese and Western medicine in advanced pancreatic cancer: A double-center retrospective cohort study. World J Gastrointest Oncol 2026; 18(2): 114690 [PMID: 41695916 DOI: 10.4251/wjgo.v18.i2.114690]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.